ImmunoGen, Inc. (IMGN) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
ImmunoGen, Inc. stock price
ImmunoGen, Inc. latest news:
Immunogen secondary offering priced below Friday's closing price
Immunogen Inc. priced its secondary offering below the price of the close of shares on Friday, according to a filing with the Securities and Exchange Commission. The biotech company priced 14.5 million shares at $6.50 apiece, with an option for another 2.2 million shares to underwriters to cover overallotments. Shares finished Friday down 2.6% at $6.85, and slipped an additional 0.2% after hours. Immunogen expects to receive $88.3 million in proceeds after expenses. Shares dropped 10% to finish at $7.03 Thursday after the company announced the offering late Wednesday. Prior to the announcement of the offering, the company had 115.5 million shares outstanding.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Immunogen prices offering of 14.5 mln common shares at $6.50 per share
* Immunogen announces pricing of public offering of common
Immunogen shares fall after secondary share offering announced
Immunogen Inc. shares fell in the extended session Wednesday after the biotech company announced a secondary offering of shares. Immunogen shares fell 10% to $7.05 after hours. The company said it plans to offer 13 million shares, and provide underwriters with up to 2 million shares to cover overallotments. Jefferies, Leerink Partners and RBC Capital Markets are listed as underwriters. Immunogen intends to use proceeds to finance research and development, clinical trials and for other corporate purposes. Immunogen has 115.5 million shares outstanding.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-ImmunoGen intends to offer and sell 13 mln shares of common stock
ImmunoGen Inc(IMGN). * ImmunoGen announces proposed public offering of common stock. * ImmunoGen Inc(IMGN) - intends to offer and sell 13 million shares of its common stock Source text for Eikon: Further company coverage:
ImmunoGen Riding High on Jazz Pharma Deal
ImmunoGen and Jazz Enter Into Global Collaboration
Impax Laboratories, Inc.IPXL
Imprimis Pharmaceuticals, Inc.IMMY
INC Research Holdings, Inc.INCR
Independent Bank Corp.INDB
Independent Bank CorporationIBCP
Independent Bank Group, IncIBTX
Industrial Services of America, Inc.IDSA